IR Presentation. for Growth. NEW Run for Growth. This IR Presentation contains forward-looking statements that involve risks and uncertainties.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
This IR Presentation contains forward-looking statements that involve risks and uncertainties.
The actual results may differ from those we project and may be affected by business environment, government regulation and legislation, financial market movement, etc.
Onsan (API, Agrochemicals)
2007 Overseas Sales
Annual Results (Bil KRW)
Quarterly Results(Bil KRW)
20 15 10 5 1
’02 ’04 ’06 ‘08 ’10
Market & Customer
Number of products
- 5-dayCAP, AECB, ABS
- Excellent efficacy, better patient compliance
- US : Launched in Sep. 2004 (Oscient)
- Mexico (Pfizer), Canada (Abbott), EU (Menarini) : Sub-licensed by Oscient
- Russia, South Africa, China, Brazil, Turkey, Middle East, etc. : Launching
Enhancing R&D productivity
Focused R&D (Outside-In)
Risk Management (Open Innovation)
LG’s vision is to become the best in its class
By winning customer’s acclaim
as a leader in the global market
“Jeong-Do” Management is LG’s unique
code of conduct that governs our management
activities. The English translation of
“Jeong-Do” is “the right way”.
Code of Conduct
- LG provides equal
opportunities for its
- LG rewards its employees
based on their capabilities
- LG serves customers
- LG strives to build
Respecting Human dignity
Creating value for customers